H.R. 5629

Summary

H.R. 5629, to provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect, was introduced in the House on Sep 30, 2025 by Rep. Erin Houchin (R). It was referred to Energy And Commerce, and last saw action on Sep 30, 2025: Referred to the House Committee on Energy and Commerce.

Record

Text

H.R. 5629 has no co-sponsors and has not gone to a roll call.

119 HR 5629 IH: To provide that the final rule of the Department of Health and Human Services titled “Medications for the Treatment of Opioid Use Disorder”, except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
 U.S. House of Representatives
 2025-09-30
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 5629  IN THE HOUSE OF REPRESENTATIVES   September 30, 2025   Mrs. Houchin  introduced the following bill; which was referred to the  Committee on Energy and Commerce    A BILL
To provide that the final rule of the Department of Health and Human Services titled  Medications for the Treatment of Opioid Use Disorder , except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
1.
Rule relating to medications for the treatment of opioid use disorder
(a)
In general
Except as provided by subsection (b), the final rule of the Department of Health and Human Services titled  Medications for the Treatment of Opioid Use Disorder  (89 Fed. Reg. 7549; published February 2, 2024) shall have no force or effect.
(b)
Exception
Subsection (a) shall not apply to the portion of the final rule that makes modifications to subpart B of part 8 of title 42, Code of Federal Regulations (relating to accreditation of opioid treatment programs).

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Sponsors

Rep. Erin Houchin (R) sponsors H.R. 5629 alone.

Erin Houchin

Rep. · R–IN-9 · Sponsor

Show 1 of 1 row

PreviousNext

Committees

H.R. 5629 went before 1 committee: Energy and Commerce.

Energy and Commerce

Energy and Commerce

Referred To · Sep 30, 2025 · 1,636 Bills

Actions

H.R. 5629 has taken 2 actions since Sep 30, 2025.

Votes

H.R. 5629 has not gone to a roll call.

Titles

H.R. 5629 goes by 2 titles.

• To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. — Official Title as Introduced
• To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. — Display Title

Lobbying

16 clients hired 16 firms and 79 registered lobbyists who named H.R. 5629 in 25 quarterly filings, 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Health Issues, Medicare/Medicaid, Budget/Appropriations, Pharmacy, Education, Immigration, Taxation/Internal Revenue Code, Veterans.

Clients

Who paid to be heard, by how many filings named the bill.

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill. The 20 named most often, of 79.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

Classification

The Congressional Research Service files H.R. 5629 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 5629’s is Health.

Source: congress.gov · legiscan.com